Lawyers Dicle Doğan

Dicle Doğan

Dicle Doğan

Gün + Partners

Dicle Doğan is a managing associate in Gün + Partners and she has been working for the firm since 2011.

Dicle has been specialized on life sciences, data protection and privacy and intellectual property with a special focus on trademarks and designs.

She advises corporate clients from life sciences sector, especially multinational pharmaceutical and medical device companies and industry associations. She advises and represents her clients on a wide range of issues including promotional activities, advertisement, labelling requirements, clinical trials, marketing authorization procedures, pricing and reimbursement regulations, and also assists clients in their day-to-day business activities. She is also experienced in cases of cancellation of administrative acts, including Regulations and Communiqués, issued by public institutions.

Dicle also advises corporate healthcare companies on the protection of personal data and privacy issues.

In the field of intellectual property, especially on trademarks and designs, in addition to counselling clients regarding their IP strategies and providing legal opinions, she has been involved in many litigation processes, where she represents the clients before the Courts in cancellation, invalidation, infringement, unfair competition actions and other types of actions. At the same time, she supervises and drafts oppositions and appeals on trademark and design applications before the Turkish Patent and Trademark Office.


Practice Areas & Work Department

Life Sciences

Intellectual Property

Trademarks and Designs

Data Protection and Privacy


Languages

English

Turkish

French

German

Torba Kanun ile İlaç Mevzuatında Değişiklikler

1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu’nundaki klinik araştırma hükümlerinde değişiklik yapılmasını öngören Sağlıkla İlgili Bazı Kanunlarda ve 663 Sayılı Kanun Hükmünde Kararnamede Değişiklik Yapılmasına Dair Kanun 1 Mart 2024 tarihli ve 32476 sayılı Resmi Gazete’de yayımlanmıştır.

22.03.2024

Omnibus Law Amends Pharmaceutical Legislation

On 1 March 2024, the Omnibus Law Amending Certain Laws and Decree Law No. 663 (the “Omnibus Law”), which amends certain provisions of the Law No. 1262 on Pharmaceuticals and Medical Preparations (the “Law No. 1262”) and the Fundamental Law on Healthcare Services No. 3359 (the “Law No. 3359”), was published in the Official Gazette numbered 32476.

21.03.2024

Named Patient Program in Turkey - 2024

Named Patient Program (“NPP”) is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized but unavailable in the Turkish market for various reasons.

18.03.2024

Combating Counterfeit and Smuggled Drugs

Foreign pharmaceutical trademarks, in principle, are registered in the name of the companies in the countries where they are established, and trademark protection procedures are managed by those companies. Although affiliates in Türkiye are not a party to trademark protection proceedings, since they become the marketing authorization holders of the drug, they are considered the relevant addressee of the Ministry of Health (“MoH”) in all transactions related to the product.

12.03.2024

Gıda ve Takviye Edici Gıdalardaki Sağlık Beyanı Hakkında TİTCK’dan Görüş Talep Edilebilecek

20 Nisan 2023 tarihli ve 32169 sayılı Resmî Gazetede Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı Kullanımı Hakkında Yönetmelik (“Yönetmelik”) yürürlüğe girmiş ve takviye edici gıdaların etiketinde, tanıtımında veya reklamında sağlık beyanı kullanılabilmesi için Sağlık Bakanlığı’na bağlı Türkiye İlaç ve Tıbbi Cihaz Kurumu’ndan (“TİTCK”) izin alınması gerekliliği kaldırılmıştır.

18.02.2024

Agency Opinion on Health Claims in Food and Food Supplements Can Now Be Requested

The Regulation on the Use of Health Claims for Food and Food Supplements (“Regulation”) entered into force as of its publication on the Official Gazette dated 20 April 2023, and numbered 32169; and the requirement for obtaining approval from the Turkish Medicines and Medical Devices Agency ("Agency") under the Ministry of Health for the use of health claims in the labelling, promotion or advertisement of food supplements was abolished.

18.02.2024

Ecza Depoları Haricinde İlaç İhracatı Yapabileceklere İlişkin Koşullar Yayınlandı

Türkiye İlaç ve Tıbbi Cihaz Kurumu (“TİTCK”) tarafından Ecza Ticarethanesi Haricinde Yapılacak İhracat Koşullarına İlişkin Kılavuz (“Kılavuz”) 29 Aralık 2023 tarihinde yayınlanıp yürürlüğe girmiştir. Bu Kılavuz, kamu sağlığı korunarak, beşeri tıbbi ürünler ile özel tıbbi amaçlı gıda ürünlerinin ulusal ve uluslararası standartlara uygun olarak sevkiyat ve ihracat işlemlerinin gerçekleştirilmesi amacıyla hazırlanmıştır.

02.02.2024

New Exemption for Procurements of the State Supply Office

With the Law No. 7491 published in the Official Gazette dated 28 December 2023, an additional article 12 was added to the Public Procurement Law (the “Law”). Accordingly, a new exemption has been introduced for procurements of vehicles, vehicle renting, fuel, medicines, medical supplies and medical devices which are to be made by the General Directorate of State Supply Office (“DMO”) on behalf of the administrations.

28.01.2024
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent